Indogulf Cropsciences Ltd — Q4 FY26 earnings call
Summary generated by AI from the official transcript Indogulf Cropsciences Ltd filed with BSE on 02 Jun 2026. Every statement cites a verbatim quote from that document — open any citation to read it. This is a record of what management said, not a recommendation. How we check these summaries
The short read
Indogulf Cropsciences reported Q4 FY26 revenue of Rs 151 crore, up 19% year-on-year, while EBITDA margin declined to 13.5% from 16.5% due to higher employee costs and input price volatility. For the full year FY26, revenue grew 19% to Rs 705 crore with PAT growing 27% to Rs 40 crore. Management discussed capacity utilization improving to 52%, ongoing expansion at the Barwasni facility, new export markets including Venezuela and Taiwan, and monitored risks from potential El Nino conditions and geopolitical tensions affecting raw material costs.
Numbers mentioned
Revenue: INR151 crores (Q4 FY26)
p. 6
“For the quarter ended March 31, '26, revenue from the operations stood at INR151 crores as compared to INR126 crores in Q4 FY25, registering a growth of 19% year-on-year basis”
Manoj Gupta, page 6 of the filed PDF · View the filing
EBITDA: INR20 crores (Q4 FY26)
p. 6
“EBITDA of Q4 stood INR20 crores as against INR21 crores in Q4 FY25.”
Manoj Gupta, page 6 of the filed PDF · View the filing
EBITDA margin: 13.5% (Q4 FY26)
p. 6
“EBITDA margins for the quarter stood 13.5% as compared to 16.5% in the corresponding period, last year.”
Manoj Gupta, page 6 of the filed PDF · View the filing
Profit before tax: INR14 crores (Q4 FY26)
p. 6
“Profit before-tax for the Q4 stood of INR14 crores as compared to INR15 crores in Q4 FY25”
Manoj Gupta, page 6 of the filed PDF · View the filing
Profit after tax: INR12 crores (Q4 FY26)
p. 6
“profit after-tax stood INR12 crores as against INR10 crores in the same quarter last year, registering growth of 19% year-on-year basis”
Manoj Gupta, page 6 of the filed PDF · View the filing
PAT margin: 7.7% (Q4 FY26)
p. 6
“PAT margin of Q4 remains stable at 7.7%.”
Manoj Gupta, page 6 of the filed PDF · View the filing
Revenue: INR705 crores (FY26)
p. 6
“For the full year FY26, revenue from the operations stood at INR705 crores, as compared to INR590 crores in FY25, reflecting a strong growth of 19% year-on-year basis.”
Manoj Gupta, page 6 of the filed PDF · View the filing
EBITDA: INR74 crores (FY26)
p. 7
“FY26 EBITDA stood INR74 crores as compared to INR60 crores in FY25, registering growth of 15% year-on-year basis.”
Manoj Gupta, page 7 of the filed PDF · View the filing
EBITDA margin: 10.4% (FY26)
p. 7
“EBITDA margins of for FY26 stood at 10.4%.”
Manoj Gupta, page 7 of the filed PDF · View the filing
Profit before tax: INR53 crores (FY26)
p. 7
“Profit before-tax FY26 stood INR53 crores as against INR45 crores in FY25”
Manoj Gupta, page 7 of the filed PDF · View the filing
Profit after tax: INR40 crores (FY26)
p. 7
“while profit after-tax stood INR40 crores as compared to INR32 crores in the previous year, registering a growth of 27%.”
Manoj Gupta, page 7 of the filed PDF · View the filing
PAT margin: 5.6% (FY26)
p. 7
“PAT margins improved 5.6% during FY26, supported by better scale, improving operational efficiency and disciplined cost management.”
Manoj Gupta, page 7 of the filed PDF · View the filing
Crop protection revenue contribution: approximately 85% (FY26)
p. 7
“crop protection continued to remain the large contributors to revenue and approximately 85% contribution during FY26.”
Manoj Gupta, page 7 of the filed PDF · View the filing
Biological revenue contribution: around 6% (FY26)
p. 7
“Biological contribute around 6%, while Plant Nutrition contribute approximately 5% to overall revenue.”
Manoj Gupta, page 7 of the filed PDF · View the filing
Capacity utilization: 52% (FY26)
p. 5
“During FY26, our overall capacity utilization improved to around 52%, reflecting improving operational efficiencies and better utilization of manufacturing infrastructure.”
Sanjay Aggarwal, page 5 of the filed PDF · View the filing
Capacity utilization improvement: from 44% to 52% (FY23-FY26)
p. 7
“capacity utilization has improved steadily from 44%, in FY23 to 52% in FY26, reflecting better demand visibility, improved manufacturing utilization and operational scalability.”
Manoj Gupta, page 7 of the filed PDF · View the filing
B2C revenue contribution: approximately 50% (FY26)
p. 7
“the B2C segment, contribute approximately 50% of FY26 revenues supported by deeper farmer engagement, strong field execution and wider distribution reach.”
Manoj Gupta, page 7 of the filed PDF · View the filing
B2B revenue contribution: 38% (FY26)
p. 7
“B2B contribution stood at 38% driven by stable institutional demand and long-standing customer relationship, while export contribute around 11%”
Manoj Gupta, page 7 of the filed PDF · View the filing
Capex spent on Unit 5: around INR76 crores
p. 16
“Till date we have done around INR76 crores and additional will be around INR8 crores to INR10 crores.”
Manoj Gupta, page 16 of the filed PDF · View the filing
Captive consumption: approximately 32% (Q4 FY26)
p. 10
“even in Q4 our captive consumption was approximately 32%.”
Sanjay Aggarwal, page 10 of the filed PDF · View the filing
New specialty products' revenue contribution: around 16% (FY26)
p. 17
“last 3 years new products which have been specialty products in FY26 they contributed to around 16% of the total revenue.”
Sanjay Aggarwal, page 17 of the filed PDF · View the filing
Debt-equity ratio: 0.4%
p. 18
“my debt-equity ratio, that has come down drastically from 0.8% to 0.4%.”
Manoj Gupta, page 18 of the filed PDF · View the filing
What management said it would do
A record of statements made on the call, in the words management used. Parakho does not forecast, endorse or assess them, and their presence here is not a view on whether they will happen.
Barwasni facility commissioning — operational · end of FY27
stated firmly by Sanjay Aggarwal
p. 13
“it will be operational by the end of this fiscal year.”
Sanjay Aggarwal, page 13 of the filed PDF · View the filing
Unit 5 commissioning — by end of Q3, definitely by Q4
stated conditionally by Sanjay Aggarwal
p. 15
“So this year end is you can say is possible by Q3, but definitely it will be done by the end of Q4.”
Sanjay Aggarwal, page 15 of the filed PDF · View the filing
Additional capex for Unit 5 — INR8 crores to INR10 crores
stated firmly by Manoj Gupta
p. 16
“Till date we have done around INR76 crores and additional will be around INR8 crores to INR10 crores.”
Manoj Gupta, page 16 of the filed PDF · View the filing
Revenue potential from expanded plant — INR1,600 crores to INR1,800 crores · next 2 to 3 years
stated as an aspiration by Sanjay Aggarwal
p. 16
“we are looking for four-digit figures very shortly in next 2 to 3 years and heading forward for this achievement for INR1,500 crores-INR1,600 crores.”
Sanjay Aggarwal, page 16 of the filed PDF · View the filing
Biologicals and plant nutrients revenue mix — next 2 to 3 years
stated as an aspiration by Sanjay Aggarwal
p. 15
“Of course, it will not reduce, it will grow and that is the basically mantra of our bottom line.”
Sanjay Aggarwal, page 15 of the filed PDF · View the filing
Raw material price outlook — Q2 FY27
stated conditionally by Sanjay Aggarwal
p. 10
“In Q2, we expect the price of our products to increase a little and that will help us to maintain the profitabilities.”
Sanjay Aggarwal, page 10 of the filed PDF · View the filing
Capacity utilization improvement — FY27
stated as an aspiration by Sanjay Aggarwal
p. 11
“the improvement will be there in this year as well.”
Sanjay Aggarwal, page 11 of the filed PDF · View the filing
Fungicide product launch — August
stated firmly by Sanjay Aggarwal
p. 17
“A fungicide we shall be launching in August.”
Sanjay Aggarwal, page 17 of the filed PDF · View the filing
ICAR-IARI research program outcomes — FY28
stated as an aspiration by Sanjay Aggarwal
p. 12
“in FY28 we will be coming up with certain good possibilities and certain good solutions for the farmers.”
Sanjay Aggarwal, page 12 of the filed PDF · View the filing
FY27 revenue and margin growth — FY27
stated as an aspiration by Sanjay Aggarwal
p. 14
“it's a forward-looking statement and I don't want to comment.”
Sanjay Aggarwal, page 14 of the filed PDF · View the filing
Q&A highlights
Management's answers to analyst questions, in Parakho's words rather than a transcript. Each row names who answered and carries the verbatim quote it was drawn from.
Management said it relies on internal accruals, bank relationships, and improved collections via early payment discounts.
Answered by Sanjay Aggarwal
Asked by Nikita Mehta: How is the company approaching working capital management given the seasonal nature of the business?
p. 8
“we are helping these things through our internal accruals and our banks we have a good relations.”
Sanjay Aggarwal, page 8 of the filed PDF · View the filing
Management attributed it to improved product mix, demand generation through IDOs, growth in biologicals, distribution expansion, and cost control.
Answered by Sanjay Aggarwal
Asked by Mahesh Kumar: What drove PAT growth outpacing revenue growth in FY26?
p. 8
“So the one was our product mix. That product mix has given us this opportunity.”
Sanjay Aggarwal, page 8 of the filed PDF · View the filing
Management said cotton cultivation could offset El Nino impact via higher insecticide demand, while exports may see a temporary Q1 hit before stabilizing in Q2.
Answered by Sanjay Aggarwal
Asked by Urmish Shah: How is management viewing the possible El Nino impact on domestic demand and exports?
p. 10
“Yes, the impact may be seen in Q2 in South of India, because of this El Nino.”
Sanjay Aggarwal, page 10 of the filed PDF · View the filing
Management said construction is complete, capacity will increase 30-40%, and the plant should be operational by the end of the fiscal year pending regulatory approvals.
Answered by Sanjay Aggarwal
Asked by Harshit Khadka: What is the status of the Barwasni facility expansion and its timeline?
p. 13
“the capacities we are almost increasing by 30% to 40% in that plant.”
Sanjay Aggarwal, page 13 of the filed PDF · View the filing
Management declined to give forward guidance figures but expressed confidence in the business trajectory.
Answered by Sanjay Aggarwal
Asked by Harshit Khadka: Can revenue growth of 19-20% and margins of 10-11% be assumed for FY27?
p. 14
“it's a forward-looking statement and I don't want to comment.”
Sanjay Aggarwal, page 14 of the filed PDF · View the filing
Management said around INR76 crore has been spent with an additional INR8-10 crore planned, targeting a potential top line of INR1,600-1,800 crore from the expanded capacity.
Answered by Sanjay Aggarwal
Asked by Deepak Poddar: What is the capex for Unit 5 and its revenue potential?
p. 16
“the possibility from this plant is to achieve a top line as high as up to INR1,600 crores to INR1,800 crores.”
Sanjay Aggarwal, page 16 of the filed PDF · View the filing
Management said Venezuela delivered about INR4 crore from a branded nutrient shipment, Taiwan started with a technical shipment, and Sudan has not yet succeeded, while Sri Lanka showed recent success with a biostimulant trial.
Answered by Sanjay Aggarwal
Asked by Ankit R: What is the revenue contribution and ramp-up status of new export markets like Venezuela, Sudan, and Taiwan?
p. 17
“we have successfully delivered Venezuela, the approximately I think it accounts INR4 crores of revenue.”
Sanjay Aggarwal, page 17 of the filed PDF · View the filing
Management said incremental debt needs would be limited due to strong creditor support and improving debt-equity ratio, though some working capital debt may be required.
Answered by Sanjay Aggarwal
Asked by Amit Mehendale: What is the debt outlook as revenue scales up?
p. 19
“the working capital requirements what I personally feel will be backed up by our domestic and overseas creditors to much extent.”
Sanjay Aggarwal, page 19 of the filed PDF · View the filing
Risks flagged
Possible El Nino conditions affecting sowing patterns and demand
p. 3
“Any adverse weather impact could influence sowing patterns, crop productivity and farmer sentiments in certain regions, which may also affect demand visibility and input price dynamics across the sector.”
Sanjay Aggarwal, page 3 of the filed PDF · View the filing
Geopolitical tensions affecting raw material and logistics costs
p. 4
“Volatility in crude oil prices and logistics cost has resulted in some unpredictability in raw material pricing across agrochemical value chains.”
Sanjay Aggarwal, page 4 of the filed PDF · View the filing
Prolonged raw material volatility affecting Q2 FY27 procurement
p. 4
“While our raw material requirements for Q1 FY27 are largely secured, prolonged volatility may affect procurement cycles and input costs during Q2 FY27 as well.”
Sanjay Aggarwal, page 4 of the filed PDF · View the filing
Higher employee expenses and other operating costs pressuring margins
p. 6
“Higher employer expenses affected margins during the quarter, along with the increase in other operating cost and continued volatility in certain input prices and procurement-related cost.”
Manoj Gupta, page 6 of the filed PDF · View the filing
Delays in Unit 5 construction due to government construction bans
p. 15
“there had been certain delays because of 3 to 4 months stopping of the work which you must have heard in Delhi and NCR because of GRAP, the construction has been stopped by the government.”
Sanjay Aggarwal, page 15 of the filed PDF · View the filing
Export impact from geopolitical situation and increased logistics costs
p. 10
“due to this war and geopolitical situations, the logistics cost has increased.”
Sanjay Aggarwal, page 10 of the filed PDF · View the filing
Generated by claude-sonnet-5. Source: the transcript as filed with BSE. We link to the exchange's copy; we do not host transcripts. Parakho is a data and screening tool, not an investment adviser — nothing here is a recommendation to buy, sell or hold.